Joseph M. Coney, MD, FACS, reviews best practices for improving adherence to treatment among patients with diabetic macular edema through comprehensive education on the disease and available therapies.
Extending the annual screen by a year for people in England considered to be at low risk of diabetic eye disease (diabetic retinopathy) could risk critical treatment delays and/or sight loss, suggests a large, real world data study, published online in the British Journal of Ophthalmology.
Joseph M. Coney, MD, FACS, discusses the challenges physicians encounter when treating diabetic macular edema and the impact of the disease on patients’ quality of life.
Joseph M. Coney MD, FACS, discusses health equity considerations for patients with diabetic macular edema and the critical role a timely diagnosis and sufficient health literacy plays in effective therapy.